Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1948 1
1958 1
1970 1
1971 1
1974 2
1975 4
1976 2
1978 1
1979 3
1980 2
1981 3
1982 2
1983 5
1984 9
1985 7
1986 10
1987 6
1988 6
1989 6
1990 5
1991 7
1992 8
1993 10
1994 8
1995 7
1996 3
1997 3
1998 14
1999 6
2000 14
2001 10
2002 11
2003 22
2004 24
2005 6
2006 12
2007 13
2008 23
2009 34
2010 21
2011 31
2012 34
2013 25
2014 30
2015 35
2016 46
2017 42
2018 40
2019 44
2020 49
2021 40
2022 39
2023 49
2024 17

Text availability

Article attribute

Article type

Publication date

Search Results

764 results

Results by year

Filters applied: . Clear all
Page 1
Response assessment criteria for brain metastases: proposal from the RANO group.
Lin NU, Lee EQ, Aoyama H, Barani IJ, Barboriak DP, Baumert BG, Bendszus M, Brown PD, Camidge DR, Chang SM, Dancey J, de Vries EG, Gaspar LE, Harris GJ, Hodi FS, Kalkanis SN, Linskey ME, Macdonald DR, Margolin K, Mehta MP, Schiff D, Soffietti R, Suh JH, van den Bent MJ, Vogelbaum MA, Wen PY; Response Assessment in Neuro-Oncology (RANO) group. Lin NU, et al. Lancet Oncol. 2015 Jun;16(6):e270-8. doi: 10.1016/S1470-2045(15)70057-4. Epub 2015 May 27. Lancet Oncol. 2015. PMID: 26065612 Review.
CNS metastases are the most common cause of malignant brain tumours in adults. Historically, patients with brain metastases have been excluded from most clinical trials, but their inclusion is now becoming more common. ...
CNS metastases are the most common cause of malignant brain tumours in adults. Historically, patients with brain metastases have been …
Primary Brain Tumors in Adults: Diagnosis and Treatment.
Perkins A, Liu G. Perkins A, et al. Am Fam Physician. 2016 Feb 1;93(3):211-7. Am Fam Physician. 2016. PMID: 26926614 Free article. Review.
There is no specific pathognomonic feature on imaging that differentiates between primary brain tumors and metastatic or nonneoplastic disease. In cases of suspected or pathologically proven metastatic disease, chest and abdomen computed tomography may be helpful, a …
There is no specific pathognomonic feature on imaging that differentiates between primary brain tumors and metastatic or nonneoplasti …
Prevention and management of secondary central nervous system lymphoma.
Bobillo S, Khwaja J, Ferreri AJM, Cwynarski K. Bobillo S, et al. Haematologica. 2023 Mar 1;108(3):673-689. doi: 10.3324/haematol.2022.281457. Haematologica. 2023. PMID: 36384246 Free PMC article. Review.
Secondary central nervous system (CNS) lymphoma (SCNSL) is defined by the involvement of the CNS, either at the time of initial diagnosis of systemic lymphoma or in the setting of relapse, and can be either isolated or with synchronous systemic disease …
Secondary central nervous system (CNS) lymphoma (SCNSL) is defined by the involvement of the CNS, either at the …
Diagnosis and Treatment of ERBB2-Positive Metastatic Colorectal Cancer: A Review.
Strickler JH, Yoshino T, Graham RP, Siena S, Bekaii-Saab T. Strickler JH, et al. JAMA Oncol. 2022 May 1;8(5):760-769. doi: 10.1001/jamaoncol.2021.8196. JAMA Oncol. 2022. PMID: 35238866 Review.
Recent evidence indicates that anti-ERBB2 therapeutic strategies are active in patients with ERBB2-positive metastatic colorectal cancer and could potentially represent a new standard-of-care. ...Colorectal tumors that harbor ERBB2 amplification are more like …
Recent evidence indicates that anti-ERBB2 therapeutic strategies are active in patients with ERBB2-positive metastatic colorec …
Critical Care Management of Cerebral Edema in Brain Tumors.
Esquenazi Y, Lo VP, Lee K. Esquenazi Y, et al. J Intensive Care Med. 2017 Jan;32(1):15-24. doi: 10.1177/0885066615619618. Epub 2015 Dec 8. J Intensive Care Med. 2017. PMID: 26647408 Review.
Cerebral edema associated with brain tumors is extremely common and can occur in both primary and metastatic tumors. The edema surrounding brain tumors results from leakage of plasma across the vessel wall into the parenchyma secondary to disruption of the blood-bra …
Cerebral edema associated with brain tumors is extremely common and can occur in both primary and metastatic tumors. The edema surrou …
Irinotecan: 25 years of cancer treatment.
Bailly C. Bailly C. Pharmacol Res. 2019 Oct;148:104398. doi: 10.1016/j.phrs.2019.104398. Epub 2019 Aug 12. Pharmacol Res. 2019. PMID: 31415916 Review.
Nowadays, this camptothecin derivative targeting topoisomerase 1 remains largely used in combination regimen, like FOLFIRI and FOLFIRINOX, to treat metastatic or advanced solid tumors, such as colon, gastric and pancreatic cancers and others. ...It offers a large range of …
Nowadays, this camptothecin derivative targeting topoisomerase 1 remains largely used in combination regimen, like FOLFIRI and FOLFIRINOX, t …
Radiation Therapy for Brain Metastases: An ASTRO Clinical Practice Guideline.
Gondi V, Bauman G, Bradfield L, Burri SH, Cabrera AR, Cunningham DA, Eaton BR, Hattangadi-Gluth JA, Kim MM, Kotecha R, Kraemer L, Li J, Nagpal S, Rusthoven CG, Suh JH, Tomé WA, Wang TJC, Zimmer AS, Ziu M, Brown PD. Gondi V, et al. Pract Radiat Oncol. 2022 Jul-Aug;12(4):265-282. doi: 10.1016/j.prro.2022.02.003. Epub 2022 May 6. Pract Radiat Oncol. 2022. PMID: 35534352
PURPOSE: This guideline provides updated evidence-based recommendations addressing recent developments in the management of patients with brain metastases, including advanced radiation therapy techniques such as stereotactic radiosurgery (SRS) and hippocampal avoidance who …
PURPOSE: This guideline provides updated evidence-based recommendations addressing recent developments in the management of patients with br …
Differential diagnosis of T2 hyperintense brainstem lesions: Part 2. Diffuse lesions.
Guzmán-De-Villoria JA, Ferreiro-Argüelles C, Fernández-García P. Guzmán-De-Villoria JA, et al. Semin Ultrasound CT MR. 2010 Jun;31(3):260-74. doi: 10.1053/j.sult.2010.03.002. Semin Ultrasound CT MR. 2010. PMID: 20483393 Review.
Diffuse brainstem lesions are poorly defined, often large abnormalities and include tumors (gliomas and lymphomas) vasculitis (Behcet's disease), traumatic brainstem injury, degenerative disorders (Wallerian degeneration), infections, processes secondary to systemic condit …
Diffuse brainstem lesions are poorly defined, often large abnormalities and include tumors (gliomas and lymphomas) vasculitis (Behcet's dise …
Management of immune-related adverse events and kinetics of response with ipilimumab.
Weber JS, Kähler KC, Hauschild A. Weber JS, et al. J Clin Oncol. 2012 Jul 20;30(21):2691-7. doi: 10.1200/JCO.2012.41.6750. Epub 2012 May 21. J Clin Oncol. 2012. PMID: 22614989 Review.
Monoclonal antibodies directed against the immune checkpoint protein cytotoxic T-lymphocyte antigen-4 (CTLA-4; CD152)-ipilimumab and tremelimumab-have been investigated in metastatic melanoma and other cancers and have shown promising results. ...We provide a detailed desc …
Monoclonal antibodies directed against the immune checkpoint protein cytotoxic T-lymphocyte antigen-4 (CTLA-4; CD152)-ipilimumab and tremeli …
Treatment of Brain Metastases of Non-Small Cell Lung Carcinoma.
Rybarczyk-Kasiuchnicz A, Ramlau R, Stencel K. Rybarczyk-Kasiuchnicz A, et al. Int J Mol Sci. 2021 Jan 8;22(2):593. doi: 10.3390/ijms22020593. Int J Mol Sci. 2021. PMID: 33435596 Free PMC article. Review.
Lung cancer is one of the most common malignant neoplasms. As a result of the disease's progression, patients may develop metastases to the central nervous system. ...Clinical trials with TKI in patients with non-small cell lung adenocarcinoma w …
Lung cancer is one of the most common malignant neoplasms. As a result of the disease's progression, patients may develop meta …
764 results